Virology News and Research

Latest Virology News and Research

Molecule Notch involved in fear memory formation

Nature is thrifty. The same signals that embryonic cells use to decide whether to become nerves, skin or bone come into play again when adult animals are learning whether to become afraid.

7 Aug 2014

Oncolytics Biotech announces financial results and operational highlights for second quarter 2014

Oncolytics Biotech Inc. today announced its financial results and operational highlights for the second quarter ended June 30, 2014.

7 Aug 2014

Researchers plan to develop vaccine into a type of antibody serum therapy

By many estimates, an Ebola vaccine could be available in humans as early as next year. But will it be the right one? There are a number of vaccines in development and each is in a race to prove that it is most effective, safe and that it will protect the largest number of people.

7 Aug 2014

Treating Americans with untested Ebola drug raises concerns

Using the experimental drug before it is tested in clinical trials will make it difficult to determine whether it is actually safe and effective, say scientists. Meanwhile, African officials say they have been inundated with requests from dying patients and their relatives for the same treatment.

7 Aug 2014

American Journal of Public Health special issue to highlight health disparities among Veterans Affairs

In an online-only, open access special issue of the American Journal of Public Health, researchers investigate issues of health equity, quality and disparities within the Veterans Affairs health care system.

7 Aug 2014

First Edition: August 6, 2014

Today's headlines include reports about the Gallup-Healthways Well-Being Index that details how politics play a role in the nation's health care gap between red and blue states.

6 Aug 2014

Researcher examines effectiveness of brief interventions for reducing problem drug use

Peter Roy-Byrne, M.D., formerly of the University of Washington, Seattle, and colleagues write that few data exist on the effectiveness of brief (1-2 sessions) interventions for reducing problem drug use, a common issue in disadvantaged populations seeking care in safety-net medical settings (hospitals and community health clinics serving low-income patients with limited or no insurance).

6 Aug 2014

Viewpoints: Treating Ebola patients in the U.S.; Medicare costs; discouraging Medicaid enrollment

It was a commendable decision -; and more unnerving than risky -; for Emory University to accept into its hospital two Americans who contracted the deadly Ebola virus while doing humanitarian work in Africa.

6 Aug 2014

Laboratories at TSRI investigate antibodies to fight Ebola virus

Laboratories at The Scripps Research Institute (TSRI) are investigating antibodies to fight Ebola virus, including the three antibodies recently used to treat two American health care workers infected with the Ebola virus.

5 Aug 2014

Computer simulation forecasts favorable trends in eradicating hepatitis C

5 Aug 2014

Hepatitis C could become a rare disease by 2036

Effective new drugs and screening would make hepatitis C a rare disease by 2036, according to a computer simulation conducted by The University of Texas MD Anderson Cancer Center and the University of Pittsburgh Graduate School of Public Health. The results of the simulation are reported in the August 5 edition of the journal Annals of Internal Medicine.

5 Aug 2014

New technique for studying lifecycle of hepatitis B virus can help develop cure for disease

A new technique for studying the lifecycle of the hepatitis B virus could help researchers develop a cure for the disease.

5 Aug 2014

Herpes zoster vaccine effective in protecting older adults against shingles, even after chemotherapy

The herpes zoster vaccine continues to be effective in protecting older adults against shingles, even after they undergo chemotherapy, according to a Kaiser Permanente study published today in the journal Clinical Infectious Diseases.

5 Aug 2014

Biomarker for head and neck cancers identified

Although mutations in a gene dubbed "the guardian of the genome" are widely recognized as being associated with more aggressive forms of cancer, researchers at the University of California, San Diego School of Medicine have found evidence suggesting that the deleterious health effects of the mutated gene may in large part be due to other genetic abnormalities, at least in squamous cell head and neck cancers.

4 Aug 2014

Research roundup: The effect of expensive cancer therapies; missed hospital handovers; children's mental health needs

Medicare uses more than a dozen different payment systems to set payment rates for the medical items and services the program covers for beneficiaries.

4 Aug 2014

Study shows sustained immunogenicity, efficacy and safety of GlaxoSmithKline's HPV vaccine

A long-term follow-up study (HPV-023; NCT00518336) shows the sustained efficacy, immunogenicity and safety of GlaxoSmithKline's human papilloma virus (HPV) vaccine Cervarix.

1 Aug 2014

Researchers one step closer to finding treatment for dengue fever

There have been several news reports that the world's first dengue vaccine will be available next year. However, the latest clinical trials show that the vaccine only provides a protection of around 50 per cent for DENV-2 and DENV-1, which are commonly found in Singapore.

1 Aug 2014

Virology News and Research

Latest Virology News and Research

Molecule Notch involved in fear memory formation

Oncolytics Biotech announces financial results and operational highlights for second quarter 2014

Researchers plan to develop vaccine into a type of antibody serum therapy

Treating Americans with untested Ebola drug raises concerns

American Journal of Public Health special issue to highlight health disparities among Veterans Affairs

First Edition: August 6, 2014

Researcher examines effectiveness of brief interventions for reducing problem drug use

Viewpoints: Treating Ebola patients in the U.S.; Medicare costs; discouraging Medicaid enrollment

Laboratories at TSRI investigate antibodies to fight Ebola virus

Computer simulation forecasts favorable trends in eradicating hepatitis C

Hepatitis C could become a rare disease by 2036

New technique for studying lifecycle of hepatitis B virus can help develop cure for disease

Herpes zoster vaccine effective in protecting older adults against shingles, even after chemotherapy

Biomarker for head and neck cancers identified

Research roundup: The effect of expensive cancer therapies; missed hospital handovers; children's mental health needs

Study shows sustained immunogenicity, efficacy and safety of GlaxoSmithKline's HPV vaccine

Researchers one step closer to finding treatment for dengue fever

Rice, Baylor scientists analyze how influenza-related proteins help infect cells

Washington bioengineers discover potential method to protect women from contracting HIV

Virologists find cells are having to fight virus constantly, even in dormant phase

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production